{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T17:56:40Z","timestamp":1758045400132,"version":"3.44.0"},"reference-count":34,"publisher":"Federa\u00e7\u00e3o das Associa\u00e7\u00f5es de Ginecologia e Obstetr\u00edcia","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,8]]},"DOI":"10.61622\/rbgo\/2025rbgo59","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T17:49:50Z","timestamp":1757699390000},"source":"Crossref","is-referenced-by-count":0,"title":["A novel marker in the ovarian preservation approach to endometrial cancer: systemic immune inflammatory index"],"prefix":"10.61622","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2420-6233","authenticated-orcid":false,"given":"B\u00fc\u015fra","family":"\u015eahin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8315-1044","authenticated-orcid":false,"given":"Tansu Bahar","family":"G\u00fcrb\u00fcz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6558-7549","authenticated-orcid":false,"given":"Ay\u015fe Sinem Duru","family":"\u00c7\u00f6teli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0770-3334","authenticated-orcid":false,"given":"Emel Ebru","family":"Begen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9640-2714","authenticated-orcid":false,"given":"Arife","family":"AKAY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0367-5551","authenticated-orcid":false,"given":"Nurettin","family":"Boran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1011-3848","authenticated-orcid":false,"given":"Yaprak","family":"\u00dcst\u00fcn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"47794","reference":[{"issue":"3","key":"key20250912174941_B1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","unstructured":"1 Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-63. doi: 10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"key20250912174941_B2","volume-title":"T\u00fcrkiye Kanser \u0130statistikleri 2019","author":"T\u00fcrkiye","year":"2021","unstructured":"2 T\u00fcrkiye Cumhuriyeti Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131. Halk Sa\u011fl\u0131\u011f\u0131. Genel M\u00fcd\u00fcrl\u00fc\u011f\u00fc. T\u00fcrkiye Kanser \u0130statistikleri 2019. Ankara: HSGM; 2021 [cited 2025 Jun 2]. Available from: https:\/\/hsgm.saglik.gov.tr\/depo\/birimler\/kanser-db\/Dokumanlar\/Istatistikler\/Turkiye_Kanser_Istatistikleri_2019.pdf"},{"issue":"6","key":"key20250912174941_B3","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ajog.2020.12.1213","article-title":"Ovarian conservation for young women with early-stage, low-grade endometrial cancer: a 2-step schema","volume":"224","author":"Matsuo","year":"2021","unstructured":"3 Matsuo K, Mandelbaum RS, Matsuzaki S, Klar M, Roman LD, Wright JD. Ovarian conservation for young women with early-stage, low-grade endometrial cancer: a 2-step schema. Am J Obstet Gynecol. 2021;224(6):574-84. doi: 10.1016\/j.ajog.2020.12.1213","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"key20250912174941_B4","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/01.AOG.0000255980.88205.15","article-title":"Prognostic factors for uterine cancer in reproductive-aged women","volume":"109","author":"Lee","year":"2007","unstructured":"4 Lee NK, Cheung MK, Shin JY, Husain A, Teng NN, Berek JS, et al. Prognostic factors for uterine cancer in reproductive-aged women. Obstet Gynecol. 2007;109(3):655-62. doi: 10.1097\/01.AOG.0000255980.88205.15","journal-title":"Obstet Gynecol"},{"issue":"3","key":"key20250912174941_B5","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1016\/S2468-2667(18)30267-6","article-title":"Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry","volume":"4","author":"Sung","year":"2019","unstructured":"5 Sung H, Siegel RL, Rosenberg PS, Jemal A. Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry. Lancet Public Health. 2019;4(3):e137-e147. doi: 10.1016\/S2468-2667(18)30267-6","journal-title":"Lancet Public Health"},{"key":"key20250912174941_B6","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8","article-title":"Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study","volume":"60","author":"Creasman","year":"1987","unstructured":"6 Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer. 1987;60(8 Suppl):2035-41. doi: 10.1002\/1097-0142(19901015)60:8+<2035::aid-cncr2820601515>3.0.co;2-8","journal-title":"Cancer"},{"issue":"1","key":"key20250912174941_B7","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41598-020-78953-4","article-title":"Preoperative predictive factor analysis of ovarian malignant involvement in premenopausal patients with clinical stage I endometrioid endometrial carcinoma","volume":"11","author":"Chen","year":"2021","unstructured":"7 Chen Q, Feng Y, Wang W, Lv W, Li B. Preoperative predictive factor analysis of ovarian malignant involvement in premenopausal patients with clinical stage I endometrioid endometrial carcinoma. Sci Rep. 2021;11(1):1219. doi: 10.1038\/s41598-020-78953-4","journal-title":"Sci Rep"},{"issue":"3","key":"key20250912174941_B8","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.ygyno.2015.07.012","article-title":"Ovarian involvement in endometrioid adenocarcinoma of uterus","volume":"138","author":"Lin","year":"2015","unstructured":"8 Lin KY, Miller DS, Bailey AA, Andrews SJ, Kehoe SM, Richardson DL, et al. Ovarian involvement in endometrioid adenocarcinoma of uterus. Gynecol Oncol. 2015;138(3):532-5. doi: 10.1016\/j.ygyno.2015.07.012","journal-title":"Gynecol Oncol"},{"issue":"2","key":"key20250912174941_B9","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ygyno.2020.08.017","article-title":"A preoperative prediction model for predicting coexisting adnexa malignancy of patients with G1\/G2 endometrioid endometrial cancer","volume":"159","author":"Shen","year":"2020","unstructured":"9 Shen L, Xie L, Li R, Shan B, Liang S, Tian W, et al. A preoperative prediction model for predicting coexisting adnexa malignancy of patients with G1\/G2 endometrioid endometrial cancer. Gynecol Oncol. 2020;159(2):402-8. doi: 10.1016\/j.ygyno.2020.08.017","journal-title":"Gynecol Oncol"},{"issue":"2","key":"key20250912174941_B10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1006\/gyno.2001.6400","article-title":"Simultaneously detected endometrial and ovarian carcinomas--a prospective clinicopathologic study of 74 cases: a gynecologic oncology group study","volume":"83","author":"Zaino","year":"2001","unstructured":"10 Zaino R, Whitney C, Brady MF, DeGeest K, Burger RA, Buller RE. Simultaneously detected endometrial and ovarian carcinomas--a prospective clinicopathologic study of 74 cases: a gynecologic oncology group study. Gynecol Oncol. 2001;83(2):355-62. doi: 10.1006\/gyno.2001.6400","journal-title":"Gynecol Oncol"},{"issue":"4","key":"key20250912174941_B11","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/AOG.0b013e31819c7bdf","article-title":"Synchronous primary ovarian and endometrial cancers: a population-based assessment of survival","volume":"113","author":"Williams","year":"2009","unstructured":"11 Williams MG, Bandera EV, Demissie K, Rodr\u00edguez-Rodr\u00edguez L. Synchronous primary ovarian and endometrial cancers: a population-based assessment of survival. Obstet Gynecol. 2009;113(4):783-9. doi: 10.1097\/AOG.0b013e31819c7bdf","journal-title":"Obstet Gynecol"},{"issue":"47","key":"key20250912174941_B12","doi-asserted-by":"crossref","first-page":"28757","DOI":"10.18632\/oncotarget.25550","article-title":"Trends and outcomes of women with synchronous endometrial and ovarian cancer","volume":"9","author":"Matsuo","year":"2018","unstructured":"12 Matsuo K, Machida H, Blake EA, Holman LL, Rimel BJ, Roman LD, et al. Trends and outcomes of women with synchronous endometrial and ovarian cancer. Oncotarget. 2018;9(47):28757-71. doi: 10.18632\/oncotarget.25550","journal-title":"Oncotarget"},{"issue":"1","key":"key20250912174941_B13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ygyno.2006.07.003","article-title":"Feasibility of ovarian preservation in patients with early stage endometrial carcinoma","volume":"104","author":"Lee","year":"2007","unstructured":"13 Lee TS, Jung JY, Kim JW, Park NH, Song YS, Kang SB, et al. Feasibility of ovarian preservation in patients with early stage endometrial carcinoma. Gynecol Oncol. 2007;104(1):52-7. doi: 10.1016\/j.ygyno.2006.07.003","journal-title":"Gynecol Oncol"},{"issue":"3","key":"key20250912174941_B14","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ecl.2015.05.003","article-title":"Surgical menopause","volume":"44","author":"Rodriguez","year":"2015","unstructured":"14 Rodriguez M, Shoupe D. Surgical menopause. Endocrinol Metab Clin North Am. 2015;44(3):531-42. doi: 10.1016\/j.ecl.2015.05.003","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"5","key":"key20250912174941_B15","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/GME.0000000000000576","article-title":"Contributing factors for menopausal symptoms after surgical staging for endometrial cancer","volume":"23","author":"Matsuo","year":"2016","unstructured":"15 Matsuo K, Gualtieri MR, Cahoon SS, Toboni MD, Machida H, Moeini A, et al. Contributing factors for menopausal symptoms after surgical staging for endometrial cancer. Menopause. 2016;23(5):535-43. doi: 10.1097\/GME.0000000000000576","journal-title":"Menopause"},{"issue":"1","key":"key20250912174941_B16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ygyno.2010.12.326","article-title":"The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation","volume":"121","author":"Finch","year":"2011","unstructured":"16 Finch A, Metcalfe KA, Chiang JK, Elit L, McLaughlin J, Springate C, et al. The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation. Gynecol Oncol. 2011;121(1):163-8. doi: 10.1016\/j.ygyno.2010.12.326","journal-title":"Gynecol Oncol"},{"issue":"11","key":"key20250912174941_B17","doi-asserted-by":"crossref","first-page":"e553","DOI":"10.1016\/S2468-2667(19)30155-0","article-title":"Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data","volume":"4","author":"Zhu","year":"2019","unstructured":"17 Zhu D, Chung HF, Dobson AJ, Pandeya N, Giles GG, Bruinsma F, et al. Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data. Lancet Public Health. 2019;4(11):e553-e564. doi: 10.1016\/S2468-2667(19)30155-0","journal-title":"Lancet Public Health"},{"issue":"1","key":"key20250912174941_B18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/gme.0b013e31818888f7","article-title":"Increased cardiovascular mortality after early bilateral oophorectomy","volume":"16","author":"Rivera","year":"2009","unstructured":"18 Rivera CM, Grossardt BR, Rhodes DJ, Brown RD Jr, Roger VL, Melton LJ 3rd, et al. Increased cardiovascular mortality after early bilateral oophorectomy. Menopause. 2009;16(1):15-23. doi: 10.1097\/gme.0b013e31818888f7","journal-title":"Menopause"},{"issue":"3 Pt 2","key":"key20250912174941_B19","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/gme.0b013e31804c793d","article-title":"Effect of early menopause on bone mineral density and fractures","volume":"14","author":"Gallagher","year":"2007","unstructured":"19 Gallagher JC. Effect of early menopause on bone mineral density and fractures. Menopause. 2007;14(3 Pt 2):567-71. doi: 10.1097\/gme.0b013e31804c793d","journal-title":"Menopause"},{"issue":"5","key":"key20250912174941_B20","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/CCO.0000000000000969","article-title":"Ovarian preservation in gynecologic oncology: current indications and techniques","volume":"35","author":"Bizzarri","year":"2023","unstructured":"20 Bizzarri N, Pavone M, Loverro M, Querleu D, Fagotti A, Scambia G. Ovarian preservation in gynecologic oncology: current indications and techniques. Curr Opin Oncol. 2023;35(5):401-11. doi: 10.1097\/CCO.0000000000000969","journal-title":"Curr Opin Oncol"},{"issue":"11","key":"key20250912174941_B21","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1016\/S1470-2045(14)70263-3","article-title":"Cancer-related inflammation and treatment effectiveness","volume":"15","author":"Diakos","year":"2014","unstructured":"21 Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15(11):e493-503. doi: 10.1016\/S1470-2045(14)70263-3","journal-title":"Lancet Oncol"},{"issue":"10","key":"key20250912174941_B22","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrclinonc.2015.105","article-title":"Inflammation and cancer: advances and new agents","volume":"12","author":"Crusz","year":"2015","unstructured":"22 Crusz SM, Balkwill FR. Inflammation and cancer: advances and new agents. Nat Rev Clin Oncol. 2015;12(10):584-96. doi: 10.1038\/nrclinonc.2015.105","journal-title":"Nat Rev Clin Oncol"},{"key":"key20250912174941_B23","doi-asserted-by":"crossref","first-page":"7131","DOI":"10.2147\/JIR.S345790","article-title":"Systemic Immune-Inflammatory Index as a predictor of lymph node metastasis in endometrial cancer","volume":"14","author":"Lei","year":"2021","unstructured":"23 Lei H, Xu S, Mao X, Chen X, Chen Y, Sun X, et al. Systemic Immune-Inflammatory Index as a predictor of lymph node metastasis in endometrial cancer. J Inflamm Res. 2021;14:7131-42. doi: 10.2147\/JIR.S345790","journal-title":"J Inflamm Res"},{"key":"key20250912174941_B24","volume-title":"Uterine neoplasms. NCCN clinical practice guidelines in oncology, version 1","author":"National Comprehensive Cancer Network","year":"2018","unstructured":"24 National Comprehensive Cancer Network. Uterine neoplasms. NCCN clinical practice guidelines in oncology, version 1. 2018 [cited 2025 Jun 2]. Available from: https:\/\/www2.tri-kobe.org\/nccn\/guideline\/gynecological\/english\/uterine.pdf"},{"issue":"8","key":"key20250912174941_B25","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1245\/s10434-020-08261-8","article-title":"Adnexal involvement in endometrial cancer: prognostic factors and implications for ovarian preservation","volume":"27","author":"Baiocchi","year":"2020","unstructured":"25 Baiocchi G, Clemente AG, Mantoan H, da Costa WL Jr, Bovolim G, Guimaraes AP, et al. Adnexal involvement in endometrial cancer: prognostic factors and implications for ovarian preservation. Ann Surg Oncol. 2020;27(8):2822-6. doi: 10.1245\/s10434-020-08261-8","journal-title":"Ann Surg Oncol"},{"key":"key20250912174941_B26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ejogrb.2021.11.016","article-title":"Ovarian metastasis risk factors in endometrial carcinoma: a systematic review and meta-analysis","volume":"267","author":"Liang","year":"2021","unstructured":"26 Liang X, Zeng H, Chen S, Jiang M, Liu S, Fan J. Ovarian metastasis risk factors in endometrial carcinoma: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2021;267:245-55. doi: 10.1016\/j.ejogrb.2021.11.016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key20250912174941_B27","doi-asserted-by":"crossref","first-page":"704235","DOI":"10.3389\/fsurg.2021.704235","article-title":"Postoperative Systemic Immune-Inflammation Index (SII): a superior prognostic factor of endometrial cancer","volume":"8","author":"Huang","year":"2021","unstructured":"27 Huang Y, Chen Y, Zhu Y, Wu Q, Yao C, Xia H, et al. Postoperative Systemic Immune-Inflammation Index (SII): a superior prognostic factor of endometrial cancer. Front Surg. 2021;8:704235. doi: 10.3389\/fsurg.2021.704235","journal-title":"Front Surg"},{"issue":"8","key":"key20250912174941_B28","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1200\/JCO.2008.19.8150","article-title":"Safety of ovarian preservation in premenopausal women with endometrial cancer","volume":"27","author":"Wright","year":"2009","unstructured":"28 Wright JD, Buck AM, Shah M, Burke WM, Schiff PB, Herzog TJ. Safety of ovarian preservation in premenopausal women with endometrial cancer. J Clin Oncol. 2009;27(8):1214-9. doi: 10.1200\/JCO.2008.19.8150","journal-title":"J Clin Oncol"},{"issue":"1","key":"key20250912174941_B29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/AOG.0000000000001181","article-title":"Utilization and outcomes of ovarian conservation in premenopausal women with endometrial cancer","volume":"127","author":"Wright","year":"2016","unstructured":"29 Wright JD, Jorge S, Tergas AI, Hou JY, Burke WM, Huang Y, et al. Utilization and outcomes of ovarian conservation in premenopausal women with endometrial cancer. Obstet Gynecol. 2016;127(1):101-8. doi: 10.1097\/AOG.0000000000001181","journal-title":"Obstet Gynecol"},{"issue":"2","key":"key20250912174941_B30","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ygyno.2013.08.024","article-title":"Outcomes of ovarian preservation in a cohort of premenopausal women with early-stage endometrial cancer: a Korean Gynecologic Oncology Group study","volume":"131","author":"Lee","year":"2013","unstructured":"30 Lee TS, Lee JY, Kim JW, Oh S, Seong SJ, Lee JM, et al. Outcomes of ovarian preservation in a cohort of premenopausal women with early-stage endometrial cancer: a Korean Gynecologic Oncology Group study. Gynecol Oncol. 2013;131(2):289-93. doi: 10.1016\/j.ygyno.2013.08.024","journal-title":"Gynecol Oncol"},{"issue":"4","key":"key20250912174941_B31","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/AOG.0000000000001647","article-title":"Ovarian conservation and overall survival in young women with early-stage low-grade endometrial cancer","volume":"128","author":"Matsuo","year":"2016","unstructured":"31 Matsuo K, Machida H, Shoupe D, Melamed A, Muderspach LI, Roman LD, et al. Ovarian conservation and overall survival in young women with early-stage low-grade endometrial cancer. Obstet Gynecol. 2016;128(4):761-70. doi: 10.1097\/AOG.0000000000001647","journal-title":"Obstet Gynecol"},{"issue":"1","key":"key20250912174941_B32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ygyno.2009.03.032","article-title":"Ovarian preservation and staging in reproductive-age endometrial cancer patients","volume":"114","author":"Richter","year":"2009","unstructured":"32 Richter CE, Qian B, Martel M, Yu H, Azodi M, Rutherford TJ, et al. Ovarian preservation and staging in reproductive-age endometrial cancer patients. Gynecol Oncol. 2009;114(1):99-104. doi: 10.1016\/j.ygyno.2009.03.032","journal-title":"Gynecol Oncol"},{"issue":"2","key":"key20250912174941_B33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.smim.2016.03.018","article-title":"Human neutrophils: their role in cancer and relation to myeloid-derived suppressor cells","volume":"28","author":"Moses","year":"2016","unstructured":"33 Moses K, Brandau S. Human neutrophils: their role in cancer and relation to myeloid-derived suppressor cells. Semin Immunol. 2016;28(2):187-96. doi: 10.1016\/j.smim.2016.03.018","journal-title":"Semin Immunol"},{"issue":"12","key":"key20250912174941_B34","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1662708","article-title":"The role of myeloid-derived suppressor cells in endometrial cancer displaying systemic inflammatory response: clinical and preclinical investigations","volume":"8","author":"Yokoi","year":"2019","unstructured":"34 Yokoi E, Mabuchi S, Komura N, Shimura K, Kuroda H, Kozasa K, et al. The role of myeloid-derived suppressor cells in endometrial cancer displaying systemic inflammatory response: clinical and preclinical investigations. Oncoimmunology. 2019;8(12):e1662708. doi: 10.1080\/2162402X.2019.1662708","journal-title":"Oncoimmunology"}],"container-title":["Revista Brasileira de Ginecologia e Obstetr\u00edcia"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T17:49:54Z","timestamp":1757699394000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalrbgo.org\/article\/a-novel-marker-in-the-ovarian-preservation-approach-to-endometrial-cancer-systemic-immune-inflammatory-index\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":34,"alternative-id":["10.61622\/rbgo\/2025rbgo59"],"URL":"https:\/\/doi.org\/10.61622\/rbgo\/2025rbgo59","relation":{},"ISSN":["0100-7203","1806-9339"],"issn-type":[{"value":"0100-7203","type":"print"},{"value":"1806-9339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"e-rbgo59"}}